🇺🇸 RCUS — Arcus Biosciences, Inc.
Salud Compra fuertePrecio actual
19,31 USD
Máx. histórico
48,47
1807 días
Caída desde máximo
-60,16%
Rango 52 semanas
17,43 – 31,74
Variación hoy
+2,12%
Cierre anterior
18,91
Rango de hoy
18,60 – 19,61
Volumen hoy
2.076.185
Peor caída histórica
-85,83%
23/11/2021 → 04/04/2025
Aún sin recuperar
Volatilidad anualizada ⓘ
75,61%
- Nombre completo
- Arcus Biosciences, Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 601
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 41,00 USD (puede no estar actualizado)
- Primera cotización
- 15/03/2018
- Precio actualizado
- hace 15 horas
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC; BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases; and Bristol-Myers Squibb Company to develop a novel treatment regimen that delivers tumor control in kidney cancer. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/10/2019 | 8,40 | 8,50 | 8,13 | 8,44 | +0,36% | 4,40% | 182.600 |
| 17/10/2019 | 8,19 | 8,53 | 8,10 | 8,41 | +3,57% | 5,25% | 938.700 |
| 16/10/2019 | 8,15 | 8,33 | 8,00 | 8,12 | +0,87% | 4,05% | 1.116.700 |
| 15/10/2019 | 8,05 | 8,21 | 8,00 | 8,05 | +0,50% | 2,61% | 125.100 |
| 14/10/2019 | 8,17 | 8,28 | 7,99 | 8,01 | -2,32% | 3,55% | 156.000 |
| 11/10/2019 | 8,17 | 8,49 | 7,40 | 8,20 | +2,50% | 13,34% | 147.500 |
| 10/10/2019 | 7,97 | 8,11 | 7,94 | 8,00 | +0,38% | 2,20% | 105.800 |
| 09/10/2019 | 8,25 | 8,43 | 7,88 | 7,97 | -1,97% | 6,67% | 139.600 |
| 08/10/2019 | 8,00 | 8,42 | 7,92 | 8,13 | -0,85% | 6,25% | 211.600 |
| 07/10/2019 | 8,64 | 8,72 | 8,15 | 8,20 | -6,71% | 6,60% | 204.100 |
| 04/10/2019 | 8,57 | 8,81 | 8,46 | 8,79 | +1,85% | 4,08% | 87.400 |
| 03/10/2019 | 8,14 | 8,72 | 8,02 | 8,63 | +5,63% | 8,60% | 174.200 |
| 02/10/2019 | 8,43 | 8,56 | 8,03 | 8,17 | -5,00% | 6,29% | 232.900 |
| 01/10/2019 | 8,93 | 9,08 | 8,59 | 8,60 | -5,49% | 5,49% | 303.500 |
| 30/09/2019 | 10,20 | 10,21 | 8,62 | 9,10 | -10,61% | 15,59% | 505.000 |
| 27/09/2019 | 9,19 | 10,34 | 9,07 | 10,18 | +15,55% | 13,81% | 710.800 |
| 26/09/2019 | 8,98 | 9,17 | 8,51 | 8,81 | -1,89% | 7,29% | 246.800 |
| 25/09/2019 | 8,74 | 9,06 | 8,39 | 8,98 | +1,35% | 7,67% | 114.600 |
| 24/09/2019 | 9,35 | 9,35 | 8,78 | 8,86 | -3,90% | 6,10% | 120.300 |
| 23/09/2019 | 8,75 | 9,60 | 8,75 | 9,22 | +4,89% | 9,71% | 164.800 |
| 20/09/2019 | 9,02 | 9,25 | 8,73 | 8,79 | -2,66% | 5,76% | 1.435.100 |
| 19/09/2019 | 9,31 | 9,49 | 8,96 | 9,03 | -2,38% | 5,69% | 222.200 |
| 18/09/2019 | 9,61 | 9,62 | 8,88 | 9,25 | -3,44% | 7,70% | 243.300 |
| 17/09/2019 | 9,30 | 9,95 | 9,30 | 9,58 | +2,02% | 6,99% | 283.800 |
| 16/09/2019 | 9,34 | 9,82 | 9,28 | 9,39 | -0,32% | 5,77% | 156.100 |
| 13/09/2019 | 9,18 | 9,59 | 9,14 | 9,42 | +3,29% | 4,90% | 300.200 |
| 12/09/2019 | 9,41 | 9,41 | 8,77 | 9,12 | -2,04% | 6,80% | 156.500 |
| 11/09/2019 | 8,82 | 9,61 | 8,66 | 9,31 | +5,56% | 10,77% | 220.500 |
| 10/09/2019 | 7,79 | 8,87 | 7,63 | 8,82 | +12,64% | 15,92% | 225.000 |
| 09/09/2019 | 7,67 | 8,16 | 7,61 | 7,83 | +2,89% | 7,17% | 399.600 |